MiR-148a-3p targets CEMIP to suppress the genesis of gastric cancer cells
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
MiR-148a-3p targets CEMIP to suppress the genesis of gastric cancer cells
Authors
Keywords
miR-148a-3p, CEMIP, Gastric cancer, Proliferation, Apoptosis, Adhesion
Journal
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
Volume 575, Issue -, Pages 42-49
Publisher
Elsevier BV
Online
2021-08-18
DOI
10.1016/j.bbrc.2021.08.039
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- CEMIP regulates the proliferation and migration of vascular smooth muscle cells in atherosclerosis through the WNT–beta-catenin signaling pathway
- (2020) Qiang Xue et al. Biochemistry and Cell Biology
- LncRNA HOTTIP facilitates the stemness of breast cancer via regulation of miR‐148a‐3p/WNT1 pathway
- (2020) Li Han et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- A novel metastatic promoter CEMIP and its downstream molecular targets and signaling pathway of cellular migration and invasion in SCLC cells based on proteome analysis
- (2020) Li Li et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Cell migration inducing hyaluronidase 1 (CEMIP) activates STAT3 pathway to facilitate cell proliferation and migration in breast cancer
- (2020) Yu Chen et al. JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION
- MicroRNA‐148a‐3p suppresses epithelial‐to‐mesenchymal transition and stemness properties via Wnt1‐mediated Wnt/β‐catenin pathway in pancreatic cancer
- (2020) Xiaowei Fu et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- miR-148a-3p Suppresses the Proliferation and Invasion of Esophageal Cancer by Targeting DNMT1
- (2019) Yuping Wang et al. Genetic Testing and Molecular Biomarkers
- Anti-silencing function 1B histone chaperone promotes cell proliferation and migration via activation of the AKT pathway in clear cell renal cell carcinoma
- (2019) Zhou Jiangqiao et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- CEMIP promotes ovarian cancer development and progression via the PI3K/AKT signaling pathway
- (2019) Fan Shen et al. BIOMEDICINE & PHARMACOTHERAPY
- Identification of candidates for driver oncogenes in scirrhous‐type gastric cancer cell lines
- (2019) Eirin Sai et al. CANCER SCIENCE
- Circ‐SERPINE2 promotes the development of gastric carcinoma by sponging miR‐375 and modulating YWHAZ
- (2019) Jianing Liu et al. CELL PROLIFERATION
- Dissection of gastric cancer heterogeneity for precision oncology
- (2019) Shamaine Wei Ting Ho et al. CANCER SCIENCE
- Tumour exosomal CEMIP protein promotes cancer cell colonization in brain metastasis
- (2019) Gonçalo Rodrigues et al. NATURE CELL BIOLOGY
- Knockdown of CEMIP suppresses proliferation and induces apoptosis in colorectal cancer cells: downregulation of GRP78 and attenuation of unfolded protein response
- (2018) Guodong Liang et al. Biochemistry and Cell Biology
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- microRNA‐148a‐3p inhibited the proliferation and epithelial–mesenchymal transition progression of non‐small‐cell lung cancer via modulating Ras/MAPK/Erk signaling
- (2018) Qiong Xie et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Induction of KIAA1199/CEMIP is associated with colon cancer phenotype and poor patient survival
- (2015) Stephen P. Fink et al. Oncotarget
- miR-375 inhibits the proliferation of gastric cancer cells by repressing ERBB2 expression
- (2014) ZHI-YONG SHEN et al. Experimental and Therapeutic Medicine
- MicroRNA-375 Is Downregulated in Gastric Carcinomas and Regulates Cell Survival by Targeting PDK1 and 14-3-3
- (2010) Y. Tsukamoto et al. CANCER RESEARCH
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started